Drug Safety

, Volume 31, Issue 5, pp 437–439 | Cite as


The ‘Beautiful’ Risk
Conference Paper


A cosmetic is classically defined as any preparation that is applied to the skin, eyes, mouth, hair or nails for the purpose of cleansing, enhancing appearance, giving a pleasant smell or giving protection. Unlike drugs, which are used to treat or prevent a disease in the body, cosmetics are not thought to change or affect the body’s structure or functions. However, the distinction between drugs and cosmetics is sometimes not clear.

Regulations for cosmetic products primarily address the safety of products that may be used by large populations of healthy consumers. However, the efficacy and safety of cosmetic products are not reviewed or approved by national authorities before they are sold to the public.

The identification and analysis of adverse effects related to cosmetic products is a process that is currently still, to a large extent, industry driven. It is the responsibility of manufacturers to determine that products and ingredients are safe before they are marketed, and then to collect reports of adverse reactions. However, although the manufacturers do their best to monitor the safety profile of their products, we should consider that there is always a potential inherent conflict of interest.


Botulinum Toxin Contact Dermatitis Tretinoin Propolis Allergic Contact Dermatitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



No sources of funding were used to assist in the preparation of this conference paper. The authors have no conflicts of interest that are directly relevant to the content of this conference paper.


  1. 1.
    EU Cosmetics directive 76/768/EEC art.1Google Scholar
  2. 2.
    Federal Food, Drug, and Cosmetic Act. Chapter II, section 201Google Scholar
  3. 3.
    Ly F, Soko AS, Dione DA, et al. Aesthetic problems associated with the cosmetic use of bleaching products. Int J Dermatol 2007 Oct; 46 Suppl. 1: 15–7PubMedCrossRefGoogle Scholar
  4. 4.
    Rguibi M, Belahsen R. Fattening practices among Moroccan Saharawi women. East Mediterr Health J 2006 Sep; 12 (5): 619–24PubMedGoogle Scholar
  5. 5.
    Johansen JD. Fragrance contact allergy: a clinical review. Am J Clin Dermatol 2003; 4 (11): 789–98PubMedCrossRefGoogle Scholar
  6. 6.
    Mehta SS, Reddy BS. Cosmetic dermatitis: current perspectives. Int J Dermatol 2003; 42 (7): 533–42PubMedCrossRefGoogle Scholar
  7. 7.
    Council of Europe. The Council of Europe recommends a vigilance system for undesirable effects of cosmetic products (“cosmetovigilance”) [online]. Available from URL:[Accessed 2007 Dec 12]

Copyright information

© Adis Data Information BV 2008

Authors and Affiliations

  1. 1.Clinical Pharmacology UnitUniversity of VeronaVeronaItaly

Personalised recommendations